In the urgent field safety notice released in the United Kingdom, the company warned about the potential for Vercise Genus DBS IPG stimulation therapy to be transiently suspended during charging due to a device reset. Boston Scientific said the reset behavior occurs in response to the presence of potential interference during IPG charging. The IPG reset behavior is random and remote. Patients with devices exhibiting this reset behavior may not report any discernible impact.
Boston Scientific received reports of undesired sensation and/or transient worsening of movement disorder symptoms secondary to a transient loss of stimulation during IPG charging for patients with rechargeable DBS IPGs. Upon investig…